I can help you do a deep dive into MiraOne and blood tests—including what tests are available, what the results mean, and whether the testing is medically useful.
First, I want to make sure I identify the right thing, because “MiraOne” could refer to a specific lab, healthcare provider, or blood-testing service.
Mira One blood test: a deep dive
Mira One is a premium preventive-health assessment offered by PreventiveHealth.ai in partnership with GenePath Diagnostics. It combines conventional blood tests with genetic sequencing and medication-response analysis.
Blood testing
80+
Biomarkers advertised
Genetics
Whole exome sequencing
Inherited genetic variants
Drug response
Pharmacogenomics
How genes affect certain medicines
1. What blood tests are included?
According to the published Mira One panel, the tests cover the following areas.
|
Category |
Tests |
What they can help assess |
|
Blood count |
CBC / hemogram |
Anaemia, blood-cell abnormalities and clues to infection |
|
Diabetes and metabolism |
Fasting glucose, HbA1c, fasting insulin |
Blood sugar regulation and diabetes risk |
|
Heart health |
Lipid profile, lipoprotein(a) |
Cholesterol-related cardiovascular risk |
|
Liver |
Bilirubin, AST/SGOT, ALT/SGPT, ALP, GGT |
Liver injury and certain biliary conditions |
|
Kidney |
Creatinine/eGFR, urea, BUN, cystatin C, electrolytes, uric acid |
Kidney filtration and fluid/electrolyte balance |
|
Thyroid |
TSH, free T3, free T4 |
Thyroid function |
|
Hormones |
FSH, LH, testosterone, free testosterone, cortisol |
Selected reproductive and hormonal questions |
|
Vitamins |
Vitamin B12, folate, vitamin D |
Selected nutritional deficiencies |
|
Iron |
Iron studies, TIBC, ferritin |
Iron deficiency, iron stores and some anaemias |
|
Inflammation |
CRP, hs-CRP |
Inflammation; hs-CRP can help refine cardiovascular risk |
|
Selected cancer markers |
AFP, CA 19-9, CEA, PSA for men |
Specific clinical investigations, depending on the marker |
|
Urine |
Routine urinalysis |
Clues to urinary, kidney and metabolic problems |
The precise inclusions and any age- or sex-specific restrictions should be confirmed against the package you are purchasing.
2. What makes Mira One different from a normal full-body check-up?
The key difference is the attempt to interpret three types of information together.
Layer 1 — Your current health
Blood biomarkers can reveal measurable abnormalities today, such as elevated glucose, abnormal cholesterol, reduced kidney filtration or low iron stores.
Layer 2 — Your inherited risk
Whole exome sequencing examines protein-coding regions of DNA for variants associated with certain inherited disorders or disease predispositions.
Layer 3 — Your response to medicines
Pharmacogenomics assesses selected genetic variants that may affect how you metabolise or respond to particular medications.
The potential advantage is context. For example, a cholesterol result might be considered alongside inherited cardiovascular risk, while a medication decision might be informed by a relevant pharmacogenomic result.
However, combining more information does not automatically make every diagnosis more accurate or every treatment decision better. The usefulness depends on the specific test, the quality of interpretation and whether the finding changes clinical management.
3. The important question: is it worth ₹99,900?
Mira One’s published FAQ lists a price of ₹99,900 for the comprehensive package, including testing and genetic counselling. Confirm the current price and inclusions before paying.
My assessment is that this is not a straightforward blood-test purchase. You are paying for three distinct services.
|
Component |
My assessment |
|
Comprehensive blood panel |
Useful for establishing a baseline, although many individual tests are available separately at substantially lower cost |
|
Whole exome sequencing |
Potentially valuable when there is a relevant family history, suspected inherited condition or another clear clinical indication |
|
Pharmacogenomics |
Valuable for certain drug-gene pairs, especially where clinical guidelines support using the result to guide prescribing |
|
Integrated report and counselling |
Potentially useful if the interpretation is accurate, transparent and leads to appropriate action |
The real question is not whether the package contains many tests. It is whether the extra genetic information provides meaningful benefits beyond a carefully selected medical check-up.
For someone with no symptoms and no concerning family history, a routine, risk-based check-up may be more cost-effective. For someone with a strong family history of early heart disease, inherited cancer syndromes or unusual medication responses, selected genetic testing may offer additional value.
4. The limitations you should understand before buying
A normal report does not rule out every disease.
Blood tests and exome sequencing cannot detect every condition. Some genetic changes are difficult to identify, and many common diseases are influenced by lifestyle, environment and multiple genes.
Cancer markers are not general cancer screening tests.
AFP, CEA and CA 19-9 are not reliable stand-alone tests for screening asymptomatic people for all cancers. PSA also has benefits and potential harms that should be discussed in context. An abnormal result may trigger unnecessary follow-up, while a normal result cannot exclude cancer.
Genetic risk is not destiny.
A genetic variant associated with a condition does not necessarily mean you will develop that condition. Conversely, a negative result does not eliminate inherited risk.
Drug-gene reports are not prescriptions.
Pharmacogenomic findings apply to particular medications and clinical situations. Never start, stop or change a medicine or its dose solely because of a genetic report.
Genetic privacy deserves special consideration.
DNA data can reveal information about biological relatives as well as yourself. Review the privacy policy, retention period, data-sharing arrangements and sample-disposal procedures before consenting.
Mira One’s own terms state that its reports are intended to inform discussions with clinicians, not replace diagnosis or treatment.
5. How to prepare for the blood draw
The provider’s published guidance recommends:
- Fasting overnight for 10–12 hours, with plain water allowed.
- Avoiding strenuous exercise for 8–12 hours beforehand.
- Getting adequate sleep and staying hydrated.
- Informing the team if you have an infection, fever or are menstruating, so they can advise whether to proceed.
- Telling the clinician about your current medications and supplements. Do not stop prescribed medicines to prepare for the test unless your clinician specifically instructs you to do so.
The provider currently describes home blood collection in Pune and says the integrated report typically takes around 45 days. If you are elsewhere in India, confirm collection availability and logistics first.
6. My recommendation
Before committing to the package, I would establish whether you need the full genetic assessment or mainly want a thorough health check-up. I would also ask for the exact laboratory methods, clinical interpretation policy, process for confirming important genetic findings and details of how unexpected findings are handled.
To tailor the deep dive to your situation, what are you primarily considering Mira One for?
1. Your main goal
Preventive health / full-body check-up
Investigating symptoms or abnormal blood results
Family history of disease or inherited risk
Understanding medication response
Evaluating whether ₹99,900 is worth it
2. Age group
Under 35
35–49
50–64
65 or older
3. Relevant family history
No known significant family history
Diabetes, heart disease or cancer in relatives
Disease at an unusually young age or suspected inherited condition
Not sure
Personalize my assessment